Submitted by: Submitted by jn458
Views: 10
Words: 264
Pages: 2
Category: English Composition
Date Submitted: 11/30/2015 03:22 PM
ArthoCare Case Discussion Questions
1. Was an IPO in February of 1996 a sensible financing choice for ArthroCare given its stage of
development, or do you think the company should have raised funds from private equity companies
instead? How much do you think private equity firms would have valued the company if they had
raised another round of financing from private equity firms instead of going public? [Note: from the
Table on page 5 you should be able to figure out how many common shares the company has after its 4th
round of private equity financing. Sum the preferred stock column and divide by 2, and it this to the
common shares outstanding after Round D. The latter figure is a cumulative number.
2. Evaluate the method that Volpe, Welty used to value ArthroCare at the time of the IPO. This method
is described by Paul Brown on page 8 of the case, and you might be able to infer more on the details of
the valuation method from Volpe, Welty’s research report (Exhibit 4). Do you agree with their
valuation amount? Why or why not?
3. What prices should ArthroCare charge for the controller and the wands (be specific)? Support your
recommendation. [Please be prepared to write your recommended prices on the chalkboard at the
beginning of class].
4. Should Dr. Thapliyal reduce the amount and scope of research and development in order to
concentrate on the orthopedic product line? Why or why not?
5. How should Dr. Thapliyal articulate and justify these two decisions (pricing and R&D) to the
financial community